Vaisala acquires Veriteq
Vaisala has strengthened its position in the life science market through the strategic acquisition of Veriteq Instruments Inc, a continuous monitoring system and data logger company based in Canada.
Veriteq is a provider of productised continuous monitoring systems and data logger solutions for the life science industry comprising pharmaceutical, biotechnological and medical device companies.
Life science is a focus area for Vaisala's Controlled Environments business, and the acquisition of Veriteq, with its life science emphasis, aligns with Vaisala's strategy.
"Vaisala is currently known as an instrument provider in the global pharmaceutical market. We want to strengthen our position by expanding our offering both to pharmaceutical and other life science customers. The Veriteq acquisition is a major step towards this goal, bringing additional know-how, a customer base, products and services to Vaisala," says Pirjo Kortteisto, Director of Cleanrooms and Chambers market segment.
Billion-dollar deal for UQ's molecular clamp vaccine tech
Sanofi has entered into an agreement to acquire Vicebio, a biotech company formed in 2018 to...
Director of scandal-ridden Forensic Science Queensland resigns
Dr Linzi Wilson-Wilde resigned from her position one month after being suspended by Queensland...
$492m pathology hub coming to Westmead Health Precinct
The NSW Health Pathology Statewide Hub will be delivered to Westmead Health Precinct, as part of...